Mass spectrometry and proteomics

GINYS-IRB-004
Dra. Marta Vilaseca
CORE FACILITY MANAGER
Modern proteomic tools are essential for understanding biological issues. The basic installation of mass spectrometry and proteomics (MSPCF) offers IRB Barcelona researchers and external users a series of techniques based on mass spectrometry (MS) and proteomics that can help improve the their knowledge of diseases, pathways, targets, and the effects of drugs. Develops and implements a wide range of methodologies based on mass spectrometry and applies them to various topics in structural biology, biochemistry, cell biology and, in clinics, in collaboration with IRB research groups and external researchers. . . Currently, the facility offers state-of-the-art applications in quantitative proteomics (differential expression protein analysis using targeted, multiplexing, and unlabeled strategies), high-performance post-translational modification (PTM) analysis, protein, structural MS ((biotinylation).-MS, crosslinking-MS, native MS; study of protein structure, protein complexes and their dynamic interactions) and high-throughput top-down proteomics (which characterizes intact proteins , i.e. proteoforms). The facility has extensive experience in proteomic analysis in all its approaches (e.g., intact proteins, classical proteomics, data interpretation, and analysis of large data sets) and provides knowledge about proteomics to the scientific community. Non-covalent protein-protein and protein-ligand interactions are also studied by MS and ion-coupled mobility in MS (IM / MS) in order to delve into the mechanisms of action of these proteins in biological processes.

Services

The services offered include MS, MS/MS and MSn analysis using atmospheric pressure ionisation techniques (electrospray and nanoelectrospray) coupled to LC, nanoLC or infusion inlets.

The Facility has the following lines of expertise:

Protein and Peptide Analysis
  • Identification/characterisation
    • Intact protein analysis
    • High-throughput proteomics, PTM analysis
      • Bottom-up proteomics
      • Top-down proteomics, Middle-down proteomics
    • mAbs analysis (ADC)
  • Quantitative Proteomics
    • Differential protein expression analysis
      • Label-free strategies (DDA, DIA)
      • Multiplexing strategies (iTRAQ, TMT SPS MS3, SILAC)
    • Targeted analysis (PRM)
  • Structural Proteomics
    • Native MS, IM-MS, Non covalent interactions
    • HDX-MS, Cross-linking MS, Limited proteolysis MS
    • Affinity MS (SAW-MS)
Small Molecule Analysis
  • Characterisation (on final products, exact mass and MS/MS)

Equipment

  • Orbitrap Eclipse (Thermo Scientific) (NEW 2021)

The capacity of the Facility was significantly strengthened by the acquisition of a new generation tribrid mass spectrometer that includes a quadrupole, a linear ion trap, and an Orbitrap mass analyzer. This instrument allows multiple fragmentation techniques—CID, HCD, and ETD—during any stage of MSn, with subsequent mass analysis in either the ion trap or Orbitrap mass analyser.

The instrument takes advantage of the combination of a brighter ion source than previous Orbitrap instruments, with a higher capacity transfer tube and an electrodynamic ion funnel for increased sensitivity. It is provided with an advanced active ion beam guide for improved robustness, a segmented quadrupole, and improved ion transmission and ETD performance.

Advanced vacuum technology allows tuning of the vacuum in the IRM cell to improve ion transmission and S/N for intact proteins, as well as for their fragmentation.

This instrument is used in the most challenging applications in proteomics, both in Top-down and Bottom-up approaches. It is used coupled to two nanoLC systems depending on the MS approach: a Dionex Ultimate 3000 nanoLC sytem (Thermo) or a NanoAcquity UPLC from Waters. A chip-based nanoESI interface (Advion Triversa Nanomate) is used in both cases.

  • Evosep One (New 2021)

The chromatograph Evosep One, which we use coupled to the Orbitrap Eclipse, is designed to be able to work with fast chromatographies and therefore provides real high-throughput and robust analysis, being ideal for clinical proteomic applications.
This nanoLC uses Evotips as disposable trap columns, where samples are loaded and desalted offline. The autosampler picks up the tip and integrates elution with liquid chromatography. This removes sample handling steps and reduces injection cycle overheads. Minimal wear and tear on mechanical components is ensured as all elution and gradient formation happen at low pressure. The Evotip is left for disposal after each run, which then allows partial elution to extend column lifetime. Analytically important peptides are effectively retained, and cross-contamination reduced.

The Evosep sytem facilitates the LC-MS/MS analysis of large number of samples to be able to undertake efficiently the analysis of sample cohorts in clinical and translational applications.

  • Orbitrap Fusion Lumos (Thermo Scientific) (2016)

The capacity of the Facility was significantly strengthened by the acquisition in 2016 of this tribrid mass spectrometer that includes a quadrupole, a linear ion trap, and an Orbitrap mass analyzer. This instrument allows multiple fragmentation techniques—CID, HCD, and ETD—during any stage of MSn, with subsequent mass analysis in either the ion trap or Orbitrap mass analyser.
The instrument takes advantage of the combination of a brighter ion source than previous Orbitrap instruments, with a higher capacity transfer tube and an electrodynamic ion funnel for increased sensitivity. It is provided with an advanced active ion beam guide for improved robustness, a segmented quadrupole, and improved ion transmission and ETD performance.
Advanced vacuum technology allows tuning of the vacuum in the IRM cell to improve ion transmission and S/N for intact proteins, as well as for their fragmentation.
This instrument is used in the most challenging applications in proteomics, both in Top-down and Bottom-up approaches. It is used coupled to two nanoLC systems depending on the MS approach: a Dionex Ultimate 3000 nanoLC sytem (Thermo) or a NanoAcquity UPLC from Waters. A chip-based nanoESI interface (Advion Triversa Nanomate) is used in both cases.

  • Synapt High Definition MS System (Waters-Micromass)

Synapt High Definition MS System (Waters-Micromass) (2007). Hybrid QTOF instrument with an incorporated Triwave Cell. This instrument allows tandem MS to be combined with ion mobility, thus permitting the analysis of samples differentiated not only by their mass to charge ratio, but also by their shape and size. The instrument is used to analyse the macromolecular structure and conformation of intact proteins and to study non-covalent interactions. When working in its normal configuration, the instrument is attached to a chip-based nanoESI interface (Advion Triversa Nanomate).

  • Premier XE

LCT-Premier XE (Waters-Micromass) (2007). Orthogonal acceleration time-of-fight mass spectrometer ideal for the analysis of high molecular weight compounds. This instrument has been modified to achieve inert conditions inside the ionization source, in order to allow amide H/D exchange experiments for the study of the dynamic and structural properties of proteins and their complexes. In the standard set-up configuration it works coupled to an LC device (UPLC Acquity, Waters), e.g large protein analysis (mAbs).-

  • Complementary devices
    The Facility is equipped with the following complementary devices, in addition the chromatographic systems already mentioned:

A Gelfree (Gel-Eluted Liquid Fraction Entrapment Electrophoresis) system for protein separation: Gelfree 8100 Fractionation system (Protein Discovery Inc.) (2010)

Staff

CORE FACILITY MANAGER
Dra. Marta Vilaseca | marta.vilaseca@irbbarcelona.org | 934 034 869 | ORCID | PRC Page

Publications

Functional analysis of TLK2 variants and their proximal interactomes implicates impaired kinase activity and chromatin maintenance defects in their pathogenesis
Pavinato L; Villamor-Payà M; Sanchiz-Calvo M; Andreoli C; Gay M; Vilaseca M; Arauz-Garofalo G; Ciolfi A; Bruselles A; Pippucci T; Prota V; Carli D; Giorgio E; Radio FC; Antona V; Giuffrè M; Ranguin K; Colson C; De Rubeis S; Dimartino P; Buxbaum JD; Ferrero GB; Tartaglia M; Martinelli S; Stracker TH; Brusco A
Journal Of Medical Genetics
Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
Calvet J; Berenguer-Llergo A; Gay M; Massanella M; Domingo P; Llop M; Sánchez-Jiménez E; Arévalo M; Carrillo J; Albiñana N; Arauz-Garofalo G; Orellana C; Delgado JF; Serrano A; Llobell A; Graell E; García-Manrique M; Moreno M; Galisteo C; Casado E; Navarro N; Gómez A; Garcia-Cirera S; Rusiñol M; Costa E; Clotet B; Vilaseca M; Blanco J; Gratacós J
Scientific Reports
Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis
Colome, N; Abian, J; Aloria, K; Arizmendi, JM; Barcelo-Batllori, S; Braga-Lagache, S; Burlet-Schiltz, O; Carrascal, M; Casal, JI; Chicano-Galvez, E; Chiva, C; Clemente, LF; Elortza, F; Estanyol, JM; Fernandez-Irigoyen, J; Fernandez-Puente, P; Fidalgo, MJ; Froment, C; Fuentes, M; Fuentes-Almagro, C; Gay, M; Hainard, A; Heller, M; Hernandez, ML; Ibarrola, N; Iloro, I; Kieselbach, T; Lario, A; Locard-Paulet, M; Marina-Ramirez, A; Martin, L; Morato-Lopez, E; Munoz, J; Navajas, R; Odena, MA; Odriozola, L; de Oliveira, E; Paradela, A; Pasquarello, C; de los Rios, V; Ruiz-Romero, C; Sabido, E; del Pino, MS; Sancho, J; Santamaria, E; Schaeffer-Reiss, C; Schneider, J; de la Torre, C; Valero, ML; Vilaseca, M; Wu, S; Wu, LF; de Embun, PX; Canals, F; Corrales, FJ
Journal Of Proteomics
Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in App(NL-G-F), App(NL-F), and 3xTg-AD mouse models
Pauls, E; Bayod, S; Mateo, L; Alcalde, V; Juan-Blanco, T; Sanchez-Soto, M; Saido, TC; Saito, T; Berrenguer-Llergo, A; Attolini, CSO; Gay, M; de Oliveira, E; Duran-Frigola, M; Aloy, P
Genome Medicine
Protamine characterization by top-down proteomics: Boosting proteoform identification with dbscan
Arauz-Garofalo G; Jodar M; Vilanova M; Rodriguez AdlI; Castillo J; Soler-Ventura A; Oliva R; Vilaseca M; Gay M
Proteomes

INSTITUTE

IRB Barcelona - Institut de Recerca Biomèdica

Parc Científic de Barcelona
Baldiri Reixac, 10

08028 Barcelona http://www.irbbarcelona.org/ca

DOMAINS RIS3CAT

  • Education and knowledge generation system
  • Industrial system
  • Socio-sanitary system

CATEGORIES

  • TECHNOLOGICAL EQUIPMENT
    • Other specializated laboratories
    • Proteomics
    • Spectrometry, chromatography and spectroscopy

RATES AND ACCESS

Availability Level: Low
Access Procedures:

Open

FACILITIES NETWORKS

PRB3-PROTEORED – Biomolecular Resources Platform: PROTEORED Proteomic Platform
Contribute to the design and development of projects in the field of biotechnology and biomedicine, establish new concepts in biology, identify new diagnostic and therapeutic targets, promote the development of new biopharmaceuticals and dissect the mechanism of action. of drugs and their selective effects on specific individuals.
Reach: Spain
Status: Active
CERCA - Ginys